
Rijuven: Innovating portable diagnostic devices to revolutionize care delivery and reduce costs.
Founded with a mission to revolutionize care delivery, Rijuven is a medical device company focused on developing portable point-of-care diagnostic devices. Their vision is to transform the medical device market by increasing outcomes, reducing costs, and expanding care access. Rijuven offers remote examination platforms that integrate connected devices with cloud-based analysis, enabling clinical teams to examine, monitor, and manage patients from any location, including urban health centers and refugee camps.
Rijuven's notable achievements include the development of innovative diagnostic tools that have significantly impacted primary, cardiac, and chronic care. The company's solutions have been instrumental in breaking down traditional care barriers, providing accessible healthcare to underserved populations. By saving time and costs while improving patient outcomes, Rijuven has made a substantial impact on the healthcare industry.

MedWand Solutions
medwand.com

Remmie
remmiehealth.com

Tenovi
tenovi.com

19Labs
19labs.com
MobileMedTek

Proxim Diagnostics
proximdx.com

Triomi Medical
triomi.com

TytoCare
tytocare.com

Alveo Technologies

Steth IO
stethio.com

Caretaker Medical

Octovis
octovis.com

Promedix
promedixinc.com

Chronus Health
Worldwide Innovative Healthcare
Evena Medical
evenamed.com

PointCare Technologies
pointcare.net

Avicena
avicenaheart.com

Quantified Care
quantifiedcare.com

Zurich Medical
zurichmed.com
Companies similar to Rijuven include MedWand Solutions, Remmie, Tenovi and 19Labs.
Rijuven was founded in 2012.
Rijuven's headquarters is located in Wexford, PA, US.
Rijuven's most recent funding round was for $250k (USD) in January 2015.
As of Jan 9, 2015, Rijuven has disclosed funding of $3.8M (USD).
Rijuven has 30 employees as of Feb 5, 2024.